<DOC>
	<DOC>NCT00550303</DOC>
	<brief_summary>The primary purpose is to determine bioavailability of Bazedoxifene/conjugated estrogen formulations for future testing purposes.</brief_summary>
	<brief_title>Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens</brief_title>
	<detailed_description />
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Healthy, post menopausal women ages 45 to 70 Male subjects</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>